David G. Miller, RPh, on the Drug Quality and Security Act

Published Online: Tuesday, November 12, 2013
Follow Pharmacy_Times:
In this video, David G. Miller, RPh, executive vice president and CEO of the International Academy of Compounding Pharmacists (IACP), discusses H.R. 3204, the Drug Quality and Security Act, which passed the House of Representatives on September 25, 2013. Miller explains that IACP opposes the bill because it reaffirms section 503A of the Federal Food, Drug, and Cosmetic Act rather than fixing its problems. This video was recorded at the National Community Pharmacists Association 115th Annual Convention in Orlando.

Related Articles
Lisa Faast, PharmD, pharmacy business specialist for Pharmacy Development Services, talks about how pharmacists' awareness of sterile compounding procedures has changed since the 2012 meningitis outbreak.
Lisa Faast, PharmD, pharmacy business specialist for Pharmacy Development Services, talks about how pharmacists can use their expertise to overcome negative stereotypes surrounding compounding.
Lisa Faast, PharmD, pharmacy business specialist for Pharmacy Development Services, talks about factors that can influence adding compounding services to pharmacy operations.
Lisa Faast, PharmD, pharmacy business specialist for Pharmacy Development Services, talks about how compounding can further the pharmacist's status as a trusted expert in the community.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$